Positive results for Novo’s Xultophy by Anna Smith | Jun 10, 2019 | News | 0 The insulin degludec and liraglutide combination helps patients achieve blood glucose targets. Read More
Europe expands use of diabetes drug Xultophy by Selina McKee | Sep 5, 2016 | News | 0 The European Commission has approved the expanded use of Novo Nordisk’s once-daily jab Xultophy in adults with type II diabetes and moderate renal impairment. Read More